Jan 9, 2012 | Cardiovascular Diabetology
Ramipril-based versus diuretic-based antihypertensive primary...
Previous randomized controlled trials demonstrated a protective effect of renin angiotensin system blocking agents for the development of type-2 diabetes in patients with pre-diabetes. However, there are no real-world data available to illustrate the relevance for clinical practice.
Atherosclerosis or Coronary Artery Disease Therapeutics (CAD) -...
The report identifies the key trends shaping and driving the global Atherosclerosis or Coronary Artery Disease market.
Blood pressure drugs can lower Alzheimer's risk by up to 50 per cent
Taking newer blood pressure drugs may cut the risk of Alzheimer's by up to 50 per cent, say British scientists.
Blood Pressure Targets Recommended by Guidelines and Incidence of...
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial From the UniversitA Milano-Bicocca, Ospedale San Gerardo, Monza, Milano, Italy ; Boehringer-Ingelheim, Ingelheim, Germany ; Carlos III, Hospital Clinico ... (more)
Hypertension not the silent killer
By Ingrid Pincott - North Island MidWeek Published: September 06, 2011 3:00 PM Updated: September 06, 2011 3:34 PM He had been prescribed Ramipril, an ACE inhibitor, and he wanted to know if I could help him get off the medication.
Also on Topix